Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Q1 Revenues Off Slightly, Losses Narrow

NEW YORK, April 29 - Sequenom reported a slight dropoff in first-quarter revenues today, while losses narrowed.

 

The San Diego-based genotyping company's revenues for the quarter came to $7.4 million, compared to $8.6 million for the previous year's first quarter. Losses narrowed to $8.5 million, from $127.9 million in the same period last year: Over $116.9 million of last year's first quarter losses, however reflected the cumulative effect of an accounting change.

 

The revenues for the quarter included over $3 million in consumables revenue, the company said, reflecting increased use of its MassArray genotyping platforms.

 

Sequenom's total R&D expenses decreased year-over-year, to $5.9 million, from $8.1 million in the first quarter of last year.

 

As of March 31, the company had a total of $91.9 million in cash, cash equivalents, short-term investments and restricted cash, compared to $102.6 million at the end of March 2002.

 

The company forecasted that it would have a cash balance of $70 to $75 million at the end of the year and had enough cash to last through 2005.

 

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.